ArticleAnnals of medicine and surgery (2012)2026
The effect of beetroot juice (BRJ) supplementation on exercise-induced muscle damage (EIMD): a systematic review and dose-response meta-analysis of randomized controlled trials.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This systematic review and meta-analysis was conducted to quantify the effect of beetroot juice (BRJ) supplementation on exercise-induced muscle damage (EIMD), inflammatory biomarkers, muscle function, and muscle soreness. Methods: The Robvis tool was used for assessing the risk of bias. The mean differences (MD) and 95% confidence intervals (CI) of creatine kinase (CK) levels (IU/L), C-reactive protein (CRP), interleukin (IL)-6, and tumor necrosis factor-alpha (TNF-α) (pg/ml), maximal voluntary isometric contraction (MVIC), counter movement jump (CMJ), and pressure pain threshold (PPT) (% change from baseline) were pooled using either a fixed- or random-effects model. Between-study heterogeneity was assessed using the χ Results: Seven trials met the eligibility criteria and were included in the pooled analysis. Meta-analysis indicated that BRJ supplementation significantly reduced serum CK levels [weighted mean difference (WMD) = -98.67 IU/L, 95% CI (-122.14 to -75.21), Conclusion: BRJ supplementation may improve some aspects of EIMD, including muscle damage, muscle function, and recovery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.